Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05089771 in Primary Erythromelalgia
NCT01769274Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-05089771 in erythromelalgia, sponsored by Pfizer. Started Oct 2012; status: completed.
02
Drugs
PF-05089771
03
Conditions
erythromelalgia
Beyond the preview
Go deeper on NCT01769274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769274.